Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cgnl1 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CGNL1 mRNA] | CTD | PMID:31150632 | Cgnl1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Cgnl1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CGNL1 mRNA | CTD | PMID:36331819 | Cgnl1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of CGNL1 mRNA | CTD | PMID:22206623 | Cgnl1 | Rat | 17beta-estradiol | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of CGNL1 mRNA | CTD | PMID:30165855 | Cgnl1 | Rat | 17beta-estradiol | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Estradiol results in decreased expression of CGNL1 mRNA | CTD | PMID:39298647 | Cgnl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CGNL1 mRNA | CTD | PMID:21570461 | Cgnl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CGNL1 mRNA | CTD | PMID:34747641 | Cgnl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CGNL1 mRNA | CTD | PMID:33956508 | Cgnl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CGNL1 mRNA | CTD | PMID:20106945|PMID:21632981 | Cgnl1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | 2,2',4,4',5-brominated diphenyl ether results in decreased expression of CGNL1 mRNA | CTD | PMID:26705709 | Cgnl1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of CGNL1 mRNA | CTD | PMID:30951980 | Cgnl1 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Cgnl1 (Mus musculus) | 6480464 | bisphenol S affects the methylation of CGNL1 gene | CTD | PMID:31683443 | Cgnl1 | Rat | aflatoxin B1 | affects expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CGNL1 protein | CTD | PMID:20106945 | Cgnl1 | Rat | aflatoxin B1 | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CGNL1 mRNA | CTD | PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756 | Cgnl1 | Rat | aflatoxin B1 | decreases methylation | ISO | CGNL1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CGNL1 gene | CTD | PMID:27153756 | Cgnl1 | Rat | all-trans-retinoic acid | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CGNL1 mRNA | CTD | PMID:21934132 | Cgnl1 | Rat | all-trans-retinoic acid | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CGNL1 mRNA | CTD | PMID:23724009 | Cgnl1 | Rat | aristolochic acid A | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CGNL1 mRNA | CTD | PMID:33212167 | Cgnl1 | Rat | arsenite(3-) | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CGNL1 mRNA] | CTD | PMID:32406909 | Cgnl1 | Rat | arsenous acid | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CGNL1 mRNA | CTD | PMID:26705709 | Cgnl1 | Rat | atrazine | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Atrazine results in increased expression of CGNL1 mRNA | CTD | PMID:22378314 | Cgnl1 | Rat | benzo[a]pyrene | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CGNL1 mRNA | CTD | PMID:19770486 | Cgnl1 | Rat | benzo[a]pyrene | affects methylation | ISO | CGNL1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CGNL1 5' UTR | CTD | PMID:27901495 | Cgnl1 | Rat | benzo[a]pyrene | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CGNL1 mRNA | CTD | PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424 | Cgnl1 | Rat | benzo[a]pyrene | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CGNL1 mRNA | CTD | PMID:27195522 | Cgnl1 | Rat | beta-lapachone | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of CGNL1 mRNA | CTD | PMID:38218311 | Cgnl1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CGNL1 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585 | Cgnl1 | Rat | bisphenol A | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CGNL1 mRNA | CTD | PMID:33221593 | Cgnl1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CGNL1 mRNA | CTD | PMID:32145629 | Cgnl1 | Rat | bisphenol A | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CGNL1 mRNA; bisphenol A results in increased expression more ... | CTD | PMID:29718440|PMID:37567409 | Cgnl1 | Rat | bisphenol A | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CGNL1 mRNA | CTD | PMID:30951980 | Cgnl1 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CGNL1 gene | CTD | PMID:28505145 | Cgnl1 | Rat | bisphenol F | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of CGNL1 mRNA | CTD | PMID:30951980|PMID:38685157 | Cgnl1 | Rat | caffeine | affects phosphorylation | ISO | CGNL1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of CGNL1 protein | CTD | PMID:35688186 | Cgnl1 | Rat | calcitriol | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CGNL1 mRNA | CTD | PMID:16002434 | Cgnl1 | Rat | CGP 52608 | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CGNL1 gene] | CTD | PMID:28238834 | Cgnl1 | Rat | chlorpyrifos | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CGNL1 mRNA | CTD | PMID:37019170 | Cgnl1 | Rat | choline | multiple interactions | ISO | Cgnl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Cgnl1 | Rat | cobalt dichloride | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of CGNL1 mRNA | CTD | PMID:19320972 | Cgnl1 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CGNL1 mRNA | CTD | PMID:24386269 | Cgnl1 | Rat | copper(II) sulfate | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CGNL1 mRNA | CTD | PMID:19549813 | Cgnl1 | Rat | cyclosporin A | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CGNL1 mRNA | CTD | PMID:20106945|PMID:25562108 | Cgnl1 | Rat | diarsenic trioxide | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CGNL1 mRNA | CTD | PMID:26705709 | Cgnl1 | Rat | dibutyl phthalate | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of CGNL1 mRNA | CTD | PMID:21266533 | Cgnl1 | Rat | dicrotophos | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of CGNL1 mRNA | CTD | PMID:28302478 | Cgnl1 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of CGNL1 mRNA | CTD | PMID:21551480 | Cgnl1 | Rat | dorsomorphin | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cgnl1 | Rat | doxorubicin | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CGNL1 mRNA | CTD | PMID:29803840 | Cgnl1 | Rat | entinostat | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | entinostat results in increased expression of CGNL1 mRNA | CTD | PMID:26272509 | Cgnl1 | Rat | entinostat | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cgnl1 | Rat | epoxiconazole | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CGNL1 mRNA | CTD | PMID:35436446 | Cgnl1 | Rat | ethanol | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Ethanol results in increased expression of CGNL1 mRNA | CTD | PMID:30319688 | Cgnl1 | Rat | ethanol | affects expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Ethanol affects the expression of CGNL1 mRNA | CTD | PMID:30319688 | Cgnl1 | Rat | fenthion | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of CGNL1 mRNA | CTD | PMID:34813904 | Cgnl1 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CGNL1 mRNA | CTD | PMID:24136188|PMID:24793618 | Cgnl1 | Rat | folic acid | multiple interactions | ISO | Cgnl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Cgnl1 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CGNL1 mRNA | CTD | PMID:22061828 | Cgnl1 | Rat | L-methionine | multiple interactions | ISO | Cgnl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Cgnl1 | Rat | menadione | affects expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of CGNL1 mRNA | CTD | PMID:20044591 | Cgnl1 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of CGNL1 mRNA | CTD | PMID:30467583 | Cgnl1 | Rat | methidathion | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | methidathion results in decreased expression of CGNL1 mRNA | CTD | PMID:34813904 | Cgnl1 | Rat | methylmercury chloride | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CGNL1 mRNA | CTD | PMID:23179753 | Cgnl1 | Rat | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of CGNL1 mRNA | CTD | PMID:24136188 | Cgnl1 | Rat | nickel atom | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CGNL1 mRNA | CTD | PMID:24768652|PMID:25583101 | Cgnl1 | Rat | okadaic acid | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of CGNL1 protein | CTD | PMID:38832940 | Cgnl1 | Rat | p-toluidine | increases expression | EXP | | 6480464 | 4-toluidine results in increased expression of CGNL1 mRNA | CTD | PMID:27638505 | Cgnl1 | Rat | panobinostat | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | panobinostat results in increased expression of CGNL1 mRNA | CTD | PMID:26272509 | Cgnl1 | Rat | panobinostat | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cgnl1 | Rat | paracetamol | affects expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CGNL1 mRNA | CTD | PMID:17562736 | Cgnl1 | Rat | paracetamol | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CGNL1 mRNA | CTD | PMID:29067470 | Cgnl1 | Rat | pentanal | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | pentanal results in increased expression of CGNL1 mRNA | CTD | PMID:26079696 | Cgnl1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cgnl1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CGNL1 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Cgnl1 | Rat | pirinixic acid | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CGNL1 mRNA | CTD | PMID:18301758 | Cgnl1 | Rat | propanal | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of CGNL1 mRNA | CTD | PMID:26079696 | Cgnl1 | Rat | quercetin | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CGNL1 mRNA | CTD | PMID:21632981 | Cgnl1 | Rat | SB 431542 | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CGNL1 more ... | CTD | PMID:27188386|PMID:37664457 | Cgnl1 | Rat | senecionine | decreases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | senecionine results in decreased expression of CGNL1 protein | CTD | PMID:35357534 | Cgnl1 | Rat | sevoflurane | decreases methylation | ISO | Cgnl1 (Mus musculus) | 6480464 | Sevoflurane results in decreased methylation of CGNL1 mRNA | CTD | PMID:35249202 | Cgnl1 | Rat | silicon dioxide | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of CGNL1 mRNA | CTD | PMID:25895662 | Cgnl1 | Rat | temozolomide | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of CGNL1 mRNA | CTD | PMID:31758290 | Cgnl1 | Rat | tetrachloromethane | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CGNL1 mRNA | CTD | PMID:17484886 | Cgnl1 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CGNL1 mRNA] | CTD | PMID:31150632 | Cgnl1 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CGNL1 mRNA | CTD | PMID:31150632 | Cgnl1 | Rat | thapsigargin | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | Thapsigargin results in increased expression of CGNL1 protein | CTD | PMID:24648495 | Cgnl1 | Rat | thapsigargin | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of CGNL1 mRNA | CTD | PMID:29453283 | Cgnl1 | Rat | titanium dioxide | increases expression | ISO | Cgnl1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CGNL1 mRNA | CTD | PMID:29264374|PMID:35295148 | Cgnl1 | Rat | titanium dioxide | decreases methylation | ISO | Cgnl1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CGNL1 gene | CTD | PMID:35295148 | Cgnl1 | Rat | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of CGNL1 mRNA | CTD | PMID:22967744 | Cgnl1 | Rat | trichostatin A | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CGNL1 mRNA | CTD | PMID:24935251|PMID:26272509 | Cgnl1 | Rat | trichostatin A | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Cgnl1 | Rat | triclosan | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of CGNL1 mRNA | CTD | PMID:30510588 | Cgnl1 | Rat | urethane | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Urethane results in increased expression of CGNL1 mRNA | CTD | PMID:28818685 | Cgnl1 | Rat | valproic acid | affects expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CGNL1 mRNA | CTD | PMID:25979313 | Cgnl1 | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CGNL1 mRNA | CTD | PMID:29427782 | Cgnl1 | Rat | valproic acid | multiple interactions | ISO | CGNL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Cgnl1 | Rat | valproic acid | increases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CGNL1 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369 | Cgnl1 | Rat | valproic acid | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CGNL1 mRNA | CTD | PMID:29154799 | Cgnl1 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of CGNL1 mRNA | CTD | PMID:23034163 | Cgnl1 | Rat | zoledronic acid | decreases expression | ISO | CGNL1 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of CGNL1 mRNA | CTD | PMID:24714768 | |






















